We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > TRACON

News List

TRACON Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock firstwordpharma
July 22, 2021
TRACON today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co. under which the underwriter has agreed to purchase on a firm commitment basis 2,617,802 shares of the Company's common stock
I-Mab, TRACON initiate Phase 1 Trial of the CD73 antibody TJD5 biospectrumasia
August 04, 2019
TJD5, a novel, differentiated humanized antibody against CD73
TRACON terminates Phase III trial for TRC105, Votrient combination in angiosarcoma; shares plunge firstwordpharma
April 14, 2019
Shares in TRACON Pharmaceuticals dropped as much as 45 percent Friday after the company said it was ending ……
TRACON Pharmaceuticals and I-Mab Biopharma Announce Strategic Partnerships for Multiple Immuno-Oncology Programs pharmafocusasia
December 03, 2018
TRACON Pharmaceuticals, a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer......